A New Insight into Meloxicam: Assessment of Antioxidant and Anti-Glycating Activity in In Vitro Studies
Meloxicam is a non-steroidal anti-inflammatory drug, which has a preferential inhibitory effect to cyclooxyganase-2 (COX-2). Although the drug inhibits prostaglandin synthesis, the exact mechanism of meloxicam is still unknown. This is the first study to assess the effect of meloxicam on protein gly...
Saved in:
Main Authors: | Cezary Pawlukianiec (Author), Małgorzata Ewa Gryciuk (Author), Kacper Maksymilian Mil (Author), Małgorzata Żendzian-Piotrowska (Author), Anna Zalewska (Author), Mateusz Maciejczyk (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antioxidant and Anti-Glycation Potential of H2 Receptor Antagonists-In Vitro Studies and a Systematic Literature Review
by: Grzegorz Biedrzycki, et al.
Published: (2023) -
Antiglycoxidative properties of amantadine - a systematic review and comprehensive in vitro study
by: Miłosz Nesterowicz, et al.
Published: (2023) -
Preliminary evaluation of the antiglycoxidant activity of verapamil using various in vitro and in silico biochemical/biophysical methods
by: Miłosz Nesterowicz, et al.
Published: (2023) -
Impact of Weight Loss on the Total Antioxidant/Oxidant Potential in Patients with Morbid Obesity-A Longitudinal Study
by: Barbara Choromańska, et al.
Published: (2020) -
In Vitro Antioxidant and Anti-Glycation Activity of Resveratrol and Its Novel Triester with Trolox
by: Sebastiano Intagliata, et al.
Published: (2020)